Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate and calcifediol for prevention of bone loss after acute spinal cord injury
2012-000321-41Phase 4Active
- Sponsor
- Fundación Hospital Nacional de Parapléjicos
- Start
- Mar 2012
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alendronate, calcifediol in osteoporosis, spinal cord injury (SCI), sponsored by Fundación Hospital Nacional de Parapléjicos. Started Mar 2012; status: active.
02
Drugs
alendronatecalcifediol
03
Conditions
osteoporosisspinal cord injury (SCI)
Beyond the preview
Go deeper on 2012-000321-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000321-41.